including the symmetrical aglycon HMP-Y1 (1) (hibarimicin-
mutant product Y1). A common structural feature shared by
HMP-Y1 (1) and the more complex hibarimicins is the highly
substituted AB and GH ring systems (Figure 1). In contem-
plating the development of a synthetic program directed
toward the hibarimicins and related metabolites such as
HMP-Y1 (1) we considered the development of a stereo-
controlled synthesis of the AB and GH ring systems a major
sub-goal. To this end, we have investigated the intramolecular
Diels-Alder cycloaddition of tolylsulfonyl alkynones 5a and
5b (Scheme 1). We anticipated that hydrolysis of cycloadduct
Scheme 2
Scheme 1
cis Decalin 9 with the desired sense of asymmetric induction
between the acetonide group and ring fusion hydrogen (cf.
C(9) and C(11) in 3 and 9). We also planned to evaluate the
effect of the configuration of the neighboring C(10) allylic
oxygen on the stereoselectivity of the cycloaddition process
(5a and 5b). An intramolecular Diels-Alder reaction re-
ported by Hirama and Uei leading to a substituted Decalin
en route to compactin showed that an allylic oxygen adjacent
to the diene component of the Diels-Alder reaction induced
the C(9)-C(10) relative stereochemistry shown in 4.6 We
thus anticipated that isomer 5a would constitute a matched
case and give higher selectivity for the desired cycloadduct
(4). Finally, our synthetic plan will also serve to evaluate
for the first time an arylsulfonyl alkynone as a dienophile in
a Diels-Alder reaction.7
Our route to arylsulfonyl alkynones 5a and 5b started with
aldehyde 10, which was prepared in four steps from L-tartaric
acid following a slight modification of a procedure reported
by Kibayashi.8 Addition of 1-lithio-1,3-butadiene9 to 10 gave
a 70:30 mixture of allylic alcohols 11 and 12, a ratio of
stereoisomers in accord with related aldehyde addition
reactions.10 We elected to first pursue the synthesis of
arylsulfonyl alkynone 5b, with the expectation that we would
observe the desired sense of asymmetric induction in the key
intramolecular Diels-Alder reaction based on the earlier
report from the Fallis group on a related Diels-Alder
substrate (6 f 7, Scheme 2). Allylic alcohol 11 was
converted to aldehyde 13 by a standard three-step procedure.
A key transformation was the addition of the ethynyl p-tolyl
sulfone anion to aldehyde 13. Ethynyl p-tolyl sulfone has
served as an excellent Michael acceptor and dienophile on
numerous occasions.11 However, there are no examples of
the derived anion adding to carbonyl compounds. We
4 would produce diketone 3, an intermediate that in principle
could be manipulated to ketone 2 based on earlier investiga-
tions on the hibarimicins reported from our group.4 An
important consideration in our proposed Diels-Alder cy-
cloaddition was the emergence of the C(9) stereocenter in
the configuration shown.
Among the factors to be taken into account to obtain
excellent stereoselectivity in intramolecular Diels-Alder
reactions are the incorporation of steric and rigidifying
structural features within the tether joining the diene and
dienophile. In earlier work Fallis demonstrated that the
incorporation of a trans isopropylidene acetal â to both the
diene and dienophiles serves to limit the flexibility of the
side chain. This added rigidity results in an enhancement of
the interaction between the reacting diene and dienophile
and induces excellent diastereoselectivity for the production
of substituted Decalins.5 For example, heating triene 6 in
refluxing dichloromethane resulted in exclusive production
of endo adduct 7 (Scheme 2). In this case A1,3 interaction
between the MOM ether and PMB carbinol ether groups may
contribute to the observed diastereoselectivity. Of greater
significance to our planned approach to the AB and GH ring
system of HMP-Y1 was the cycloaddition of triene 8 to give
(6) Hirama, M.; Uei, M. J. Am. Chem. Soc. 1982, 104, 4251-4253.
(7) Arylsulfonyl alkynoates: (a) Shen, M.; Schultz, A. G. Tetrahedron
Lett. 1981, 22, 3347-3350. (b) Corey, E. J.; Jardine, P. D.; Rohloff, J. C.
J. Am. Chem. Soc. 1988, 110, 3672-3673. (c) Pangka, V. R.; Morgan, A.
R.; Dolphin, D. J. Org. Chem. 1986, 51, 1094-1100.
(8) Iida, H.; Yamazaki, N.; Kibayashi, C. J. Org. Chem. 1987, 52, 3337-
3342.
(4) Lee, C. S.; Audelo, M. Q.; Reibenspies, J.; Sulikowski, G. A.
Tetrahedron 2002, 58, 4403-4409.
(5) (a) Millan, D. S.; Pham, T. T.; Lavers, J. A.; Fallis, A. G. Tetrahedron
Lett. 1997, 38, 795-798. (b) Wong, T.; Wilson, P. D.; Woo, S.; Fallis, A.
G. Tetrahedron Lett. 1997, 38, 7045-7048. (c) Melekhov, A.; Forgione,
P.; Legoupy, S.; Fallis, A. G. Org. Lett. 2000, 2, 2793-2796.
(9) Wender, P. A.; Sieburth, S. M.; Petraitis, J. J.; Singh, S. K.
Tetrahedron 1981, 37, 3967-3975.
(10) (a) Schneider, C.; Kazmaier, U. Synthesis 1998, 1314-1320. (b)
Martin, S. F.; Chen, H. J.; Lynch, V. M. J. Org. Chem. 1995, 60, 276-
278.
(11) Back, T. G. Tetrahedron 2001, 57, 5263-5301.
2778
Org. Lett., Vol. 5, No. 16, 2003